company background image
GLH

Global HealthASX:GLH Stock Report

Market Cap

AU$19.5m

7D

-1.4%

1Y

-4.2%

Updated

18 Oct, 2021

Data

Company Financials
GLH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

GLH Overview

Global Health Limited provides digital health solutions for the healthcare sector in Australia.

Price History & Performance

Summary of all time highs, changes and price drops for Global Health
Historical stock prices
Current Share PriceAU$0.34
52 Week HighAU$0.32
52 Week LowAU$0.79
Beta1.37
1 Month Change-15.85%
3 Month Change-28.13%
1 Year Change-4.17%
3 Year Change72.50%
5 Year Change-27.37%
Change since IPO-94.52%

Recent News & Updates

Dec 23
What Can We Conclude About Global Health's (ASX:GLH) CEO Pay?

What Can We Conclude About Global Health's (ASX:GLH) CEO Pay?

This article will reflect on the compensation paid to Alumootil Cherian who has served as CEO of Global Health Limited...

Shareholder Returns

GLHAU Healthcare ServicesAU Market
7D-1.4%0.2%0.9%
1Y-4.2%46.7%20.2%

Return vs Industry: GLH underperformed the Australian Healthcare Services industry which returned 46.7% over the past year.

Return vs Market: GLH underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is GLH's price volatile compared to industry and market?
GLH volatility
GLH Beta1.37
Industry Beta0.49
Market Beta1

Stable Share Price: GLH is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: GLH's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985n/aMichael Davieshttps://www.global-health.com

Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, dental, post-acute care, home and community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement form, general practice, and pharmacy. The company’s products include MasterCare EMR, an Electronic Medical Record; MasterCare + providers flexibility and accessibility managing their services and processes from anywhere; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice software for general practitioners, specialists, and allied health practitioners; ReferralNet, a secure messaging exchange; LifeCard, a personal health record.

Global Health Fundamentals Summary

How do Global Health's earnings and revenue compare to its market cap?
GLH fundamental statistics
Market CapAU$19.53m
Earnings (TTM)-AU$488.03k
Revenue (TTM)AU$7.03m

2.8x

P/S Ratio

-40.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GLH income statement (TTM)
RevenueAU$7.03m
Cost of RevenueAU$5.60m
Gross ProfitAU$1.43m
ExpensesAU$1.92m
Earnings-AU$488.03k

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0086
Gross Margin20.39%
Net Profit Margin-6.94%
Debt/Equity Ratio7.4%

How did GLH perform over the long term?

See historical performance and comparison

Valuation

Is Global Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GLH (A$0.35) is trading below our estimate of fair value (A$0.86)

Significantly Below Fair Value: GLH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GLH is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: GLH is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GLH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GLH is overvalued based on its PB Ratio (4.8x) compared to the AU Healthcare Services industry average (3.8x).


Future Growth

How is Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

40.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Global Health performed over the past 5 years?

-25.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GLH is currently unprofitable.

Growing Profit Margin: GLH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: GLH is unprofitable, and losses have increased over the past 5 years at a rate of 25.3% per year.

Accelerating Growth: Unable to compare GLH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GLH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).


Return on Equity

High ROE: GLH has a negative Return on Equity (-12.08%), as it is currently unprofitable.


Financial Health

How is Global Health's financial position?


Financial Position Analysis

Short Term Liabilities: GLH's short term assets (A$5.5M) exceed its short term liabilities (A$4.7M).

Long Term Liabilities: GLH's short term assets (A$5.5M) exceed its long term liabilities (A$339.9K).


Debt to Equity History and Analysis

Debt Level: GLH's debt to equity ratio (7.4%) is considered satisfactory.

Reducing Debt: GLH's debt to equity ratio has reduced from 47.2% to 7.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable GLH has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: GLH is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 4.8% per year.


Dividend

What is Global Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GLH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GLH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GLH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GLH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GLH's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.3yrs

Average management tenure


CEO

Michael Davies

0.25

Tenure

Mr. Michael Davies serves as the Chief Executive Officer at Global Health Limited since July 1, 2021. He has extensive background leading technology adoption, driving sales and go-to-market strategies in t...


Leadership Team

Experienced Management: GLH's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: GLH's board of directors are considered experienced (8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.5%.


Top Shareholders

Company Information

Global Health Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Global Health Limited
  • Ticker: GLH
  • Exchange: ASX
  • Founded: 1985
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$19.530m
  • Shares outstanding: 56.61m
  • Website: https://www.global-health.com

Number of Employees


Location

  • Global Health Limited
  • 696 Bourke Street
  • Level 2
  • Melbourne
  • Victoria
  • 3000
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 15:14
End of Day Share Price2021/10/18 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.